BAYER AG

BAYER AG Share · DE000BAY0017 · BAY001 (XFRA) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of BAYER AG
No Price
01.05.2026 17:40
Current Prices from BAYER AG
ExchangeTickerCurrencyLast TradePriceDaily Change
XDQU: Quotrix
Quotrix
BAGNAN17.DUSC
EUR
30.04.2026 20:35
37,86 EUR
1,54 EUR
+4,24 %
XSTU: BOERSE STUTTGART
BOERSE STUTTGART
BAYN.SG
EUR
30.04.2026 19:55
37,94 EUR
1,84 EUR
+5,10 %
XDUS: Düsseldorf
Düsseldorf
BAGNAN17.DUSA
EUR
30.04.2026 17:58
38,21 EUR
1,89 EUR
+5,20 %
XHAM: Hamburg
Hamburg
BAGNAN17.HAMA
EUR
30.04.2026 15:53
38,24 EUR
1,92 EUR
+5,29 %
XETR: XETRA
XETRA
BAYN.DE
EUR
30.04.2026 15:39
38,05 EUR
1,95 EUR
+5,40 %
XSWX: SIX
SIX
BAYN.SW
EUR
30.04.2026 08:01
33,97 EUR
-2,13 EUR
-5,90 %
XHAN: Hannover
Hannover
BAGNAN17.HANA
EUR
30.04.2026 06:16
35,92 EUR
-
XWAR: WSE
WSE
BAY.WA
PLN
29.04.2026 17:55
156,90 PLN
-
Invested Funds

The following funds have invested in BAYER AG:

Fund
iShares DivDAX® UCITS ETF (DE)
Vol. in million
42.689,80
Percentage (%)
8,40 %
Fund
iShares Core DAX® UCITS ETF (DE) EUR (Dist)
Vol. in million
59,63
Percentage (%)
3,82 %
Fund
iShares DAX® ESG UCITS ETF (DE)
Vol. in million
1.314,48
Percentage (%)
3,43 %
Fund
iShares MSCI Europe Health Care Sector UCITS ETF EUR (Acc)
Vol. in million
1.447,69
Percentage (%)
3,32 %
Fund
iShares Edge MSCI Europe Value Factor UCITS ETF EUR (Dist)
Vol. in million
1.043,15
Percentage (%)
1,68 %
Company Profile for BAYER AG Share
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, and self-care solutions in dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, and cold and cough. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration agreement with MD Anderson Cancer Center to develop oncology drugs; research and license agreement with Dewpoint Therapeutics, Inc. for the development of new treatments for cardiovascular and gynecological diseases; collaboration agreement with Exscientia Ltd, Foundation Medicine Inc., and Evotec AG; research collaboration with Arvinas Inc.; strategic research partnership with University of Oxford to develop novel gynecological therapies; and Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.

Company Data

Name BAYER AG
Company Bayer AG
Website https://www.bayer.com
Primary Exchange XFRA Frankfurt
WKN BAY001
ISIN DE000BAY0017
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - General
CEO William N. Anderson
Market Capitalization 154 Mrd.
Country Germany
Currency EUR
Employees 96,9 T
Address Kaiser-Wilhelm-Allee 1, 51368 Leverkusen
IPO Date 2000-01-03
Dividends from 'BAYER AG'
Ex-Date Dividend per Share
27.04.2026 0,11 EUR
28.04.2025 0,10 EUR
29.04.2024 0,11 EUR
02.05.2023 11,00 PLN
02.05.2022 9,40 PLN
28.04.2021 2,00 EUR
29.04.2020 2,80 EUR
29.04.2019 12,02 PLN
28.05.2018 2,76 EUR
28.04.2017 2,66 EUR

Stock Splits

Date Split
06.06.2018 127:125
03.06.1996 10:1

Ticker Symbols

Name Symbol
BOERSE STUTTGART BAYN.SG
Düsseldorf BAGNAN17.DUSA
Frankfurt BAYN.F
Hamburg BAGNAN17.HAMA
Hannover BAGNAN17.HANA
Quotrix BAGNAN17.DUSC
SIX BAYN.SW
WSE BAY.WA
XETRA BAYN.DE
More Shares
Investors who hold BAYER AG also have the following shares in their portfolio:
ALLIANZ AG
ALLIANZ AG Share
AMAZON.CO INC
AMAZON.CO INC Share
APPLE INC
APPLE INC Share
ARM HLDGS ADR NEW
ARM HLDGS ADR NEW Depository Receipt
BASF SE
BASF SE Share
INSTRUMENT DE000HX35W49
INSTRUMENT DE000HX35W49 Unknown
INVESTEC BANK PLC IMPALA TRPLE IDX 25/05/23
INVESTEC BANK PLC IMPALA TRPLE IDX 25/05/23 Bond
META PLATFORMS INC
META PLATFORMS INC Share
MICROSOFT CORP
MICROSOFT CORP Share
NVIDIA CORP
NVIDIA CORP Share
PAYPAL INC
PAYPAL INC Share
SAP SE
SAP SE Share
TESLA INC
TESLA INC Share
TOYOTA M.CRD 23/28 MTN
TOYOTA M.CRD 23/28 MTN Bond